CURX — Curanex Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $22.11m
- $22.40m
Annual balance sheet for Curanex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.002 | 0.074 |
| Net Total Receivables | 0.003 | 0 |
| Total Inventory | ||
| Total Other Current Assets | ||
| Total Current Assets | 0.01 | 0.074 |
| Total Assets | 0.01 | 0.074 |
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0 | 0.014 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 0 | 0.014 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 0.01 | 0.06 |
| Total Liabilities & Shareholders' Equity | 0.01 | 0.074 |
| Total Common Shares Outstanding |